The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Volume 331:961-967 October 13, 1994 Number 15
NextNext

Percutaneous Balloon Valvuloplasty Compared with Open Surgical Commissurotomy for Mitral Stenosis
Vincent P. Reyes, B. Soma Raju, Joshua Wynne, Larry W. Stephenson, Raghava Raju, Barbara S. Fromm, P. Rajagopal, Prabodh Mehta, Shailender Singh, D. Prasada Rao, P.V. Satyanarayana, and Zoltan G. Turi

 Sign up for free e-toc
 

This Article
-Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Percutaneous balloon mitral valvuloplasty has been proposed as an alternative to open surgical commissurotomy for the treatment of rheumatic mitral-valve stenosis.

Methods We enrolled 60 patients with severe mitral stenosis and favorable valvular anatomy in a prospective, randomized trial comparing the two procedures. All patients underwent cardiac catheterization before the procedure and one week, six months, and three years thereafter. Hemodynamic data were analyzed by investigators who were blinded to the patients' treatment assignments.

Results Mitral-valve areas improved initially in both groups, from a mean (±SD) of 0.9 ±0.3 cm2 to 2.1 ±0.6 cm2 in the balloon-valvuloplasty group (30 patients; P<0.01) and from 0.9 ±0.3 cm2 to 2.0 ±0.6 cm2 in the surgical group (30 patients; P<0.001). Although improvement was maintained in both groups, mitral-valve areas were greater in the patients in the balloon-valvuloplasty group at three years (2.4 ±0.6 cm2, vs. 1.8 ±0.4 cm2 in the surgery group; P<0.001). Restenosis occurred in three patients in the balloon-valvuloplasty group and four in the surgery group. One patient in the balloon-valvuloplasty group died of an apparent stroke after 2.5 years; four patients in the balloon-valvuloplasty group had residual atrial septal defects, and three patients (two in the balloon-valvuloplasty group and one in the surgery group) were judged to have severe mitral regurgitation. Seventy-two percent of the patients who underwent balloon valvuloplasty and 57 percent of the surgically treated patients were in New York Heart Association functional class I (i.e., they had no cardiovascular symptoms) at three years. No patient was lost to follow-up.

Conclusions In the treatment of mitral stenosis, balloon valvuloplasty and open surgical commissurotomy have comparable initial results and low rates of restenosis, and both produce good functional capacity for at least three years. The potential complications associated with balloon valvuloplasty should be noted. The better hemodynamic results at three years, lower cost, and elimination of the need for thoracotomy suggest that balloon valvuloplasty should be considered for all patients with favorable mitral-valve anatomy.


Source Information

From the Divisions of Cardiology (V.P.R., J.W., B.S.F., P.M., Z.G.T.) and Cardiothoracic Surgery (L.W.S.), Departments of Internal Medicine and Surgery, Harper Hospital, Wayne State University School of Medicine, Detroit; and the Departments of Cardiology (B.S.R., R.R., S.S.) and Cardiac Surgery (P.R., D.P.R., P.V.S.), the Nizam's Institute of Medical Sciences and MediCiti, Hyderabad, India. Presented in part in abstract form at the 63rd and 66th Scientific Sessions of the American Heart Association, Dallas, November 14, 1990, and Atlanta, November 9, 1993.

Address reprint requests to Dr. Turi at Wayne State University School of Medicine, Harper Hospital, 3990 John R., Detroit, MI 48201.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.